Literature DB >> 9864645

Sarcoidosis: a pediatric perspective.

A K Shetty1, A Gedalia.   

Abstract

Childhood sarcoidosis is a rare multisystemic granulomatous disease of unknown etiology. The clinical presentation can vary greatly depending upon the organs involved. Two distinct forms of sarcoidosis exist in children. Older children usually present with a multisystem disease similar to the adult manifestation, with frequent hilar lymphadenopathy and pulmonary infiltration. Early-onset childhood sarcoidosis is a unique form of the disease characterized by the triad of rash, uveitis, and arthritis in patients presenting before age 4 years. The diagnosis of sarcoidosis is confirmed by demonstrating a typical noncaseating granuloma on a biopsy specimen. The current therapy of choice for childhood sarcoidosis with multisystem involvement is corticosteroids. Methotrexate given orally in low doses is effective and safe and has steroid-sparing properties.

Entities:  

Mesh:

Year:  1998        PMID: 9864645     DOI: 10.1177/000992289803701201

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  12 in total

1.  Chitotriosidase as a marker of disease activity in sarcoidosis.

Authors:  Jürgen Brunner; Sabine Scholl-Bürgi; Martina Prelog; Lothar-Bernd Zimmerhackl
Journal:  Rheumatol Int       Date:  2007-01-25       Impact factor: 2.631

2.  Juvenile sarcoidosis presenting as Crohn's disease.

Authors:  Jürgen Brunner; Consolato Sergi; Thomas Müller; Ingmar Gassner; Friederike Prüfer; Lothar Bernd Zimmerhackl
Journal:  Eur J Pediatr       Date:  2006-03-18       Impact factor: 3.183

Review 3.  Management of uveitis in pediatric patients: special considerations.

Authors:  Justine R Smith
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 4.  The puzzling clinical spectrum and course of juvenile sarcoidosis.

Authors:  Andrew Fretzayas; Maria Moustaki; Olga Vougiouka
Journal:  World J Pediatr       Date:  2011-05-15       Impact factor: 2.764

Review 5.  RIP2 activity in inflammatory disease and implications for novel therapeutics.

Authors:  Janice C Jun; Fabio Cominelli; Derek W Abbott
Journal:  J Leukoc Biol       Date:  2013-06-21       Impact factor: 4.962

Review 6.  [Sarcoidosis and uveitis : An update].

Authors:  J G Garweg
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

Review 7.  [Ocular sarcoidosis].

Authors:  C Springer-Wanner; T Brauns
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

Review 8.  Current perspectives on ophthalmic manifestations of childhood rheumatic diseases.

Authors:  Neal V Palejwala; Steven Yeh; Sheila T Angeles-Han
Journal:  Curr Rheumatol Rep       Date:  2013-07       Impact factor: 4.592

9.  Sarcoidosis: child vs adult.

Authors:  Halil Yanardag; Omer Nuri Pamuk; Sedat Uygun; Sabriye Demirci; Tuncer Karayel
Journal:  Indian J Pediatr       Date:  2006-02       Impact factor: 1.967

10.  Chitotriosidase as a marker of disease activity in sarcoidosis.

Authors:  Jürgen Brunner; Sabine Scholl-Bürgi; Lothar-Bernd Zimmerhackl
Journal:  Rheumatol Int       Date:  2007-05-30       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.